FR2893841B1 - DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89) - Google Patents

DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89)

Info

Publication number
FR2893841B1
FR2893841B1 FR0511977A FR0511977A FR2893841B1 FR 2893841 B1 FR2893841 B1 FR 2893841B1 FR 0511977 A FR0511977 A FR 0511977A FR 0511977 A FR0511977 A FR 0511977A FR 2893841 B1 FR2893841 B1 FR 2893841B1
Authority
FR
France
Prior art keywords
isoquinolinesulfonamide
depigmenting
bromophenyl
propenyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0511977A
Other languages
French (fr)
Other versions
FR2893841A1 (en
Inventor
Corine Bertolotto
Robert Ballotti
Flavie Luciani
Mehdi Khaled
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires D'anjou Fr
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Galderma Research and Development SNC filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR0511977A priority Critical patent/FR2893841B1/en
Priority to PCT/EP2006/068772 priority patent/WO2007060182A1/en
Priority to ARP060105185A priority patent/AR057933A1/en
Publication of FR2893841A1 publication Critical patent/FR2893841A1/en
Application granted granted Critical
Publication of FR2893841B1 publication Critical patent/FR2893841B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
FR0511977A 2005-11-25 2005-11-25 DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89) Expired - Fee Related FR2893841B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0511977A FR2893841B1 (en) 2005-11-25 2005-11-25 DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89)
PCT/EP2006/068772 WO2007060182A1 (en) 2005-11-25 2006-11-22 Use of n-(2-((3-(4-bromophenyl)-2-propenyl)amino)ethyl)-5-isoquinolinesulfonamide (h89) in a depigmenting pharmaceutical composition
ARP060105185A AR057933A1 (en) 2005-11-25 2006-11-24 DEPIGMENTING PHARMACEUTICAL COMPOSITION INCLUDING N- (2 - ((3- (4- BROMOFENIL) - 2- PROPENIL) AMINO) ETIL) -5- ISOQUINOLINSULFONAMIDE (H89)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0511977A FR2893841B1 (en) 2005-11-25 2005-11-25 DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89)

Publications (2)

Publication Number Publication Date
FR2893841A1 FR2893841A1 (en) 2007-06-01
FR2893841B1 true FR2893841B1 (en) 2014-04-25

Family

ID=36934164

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0511977A Expired - Fee Related FR2893841B1 (en) 2005-11-25 2005-11-25 DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89)

Country Status (3)

Country Link
AR (1) AR057933A1 (en)
FR (1) FR2893841B1 (en)
WO (1) WO2007060182A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112903657B (en) * 2021-01-28 2022-06-24 中山大学 Surface enhanced Raman spectroscopy detection method for melamine and formaldehyde

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2835252B1 (en) * 2002-01-25 2005-08-05 Seppic Sa USE OF A PROTEIN KINASE A INACTIFYING COMPOUND IN A COMPOSITION CONTAINING A COSMETICALLY ACCEPTABLE MEDIUM FOR LAMINATING THE SKIN
US7256200B2 (en) * 2003-02-10 2007-08-14 The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois Method and composition for potentiating an oplate analgesic

Also Published As

Publication number Publication date
AR057933A1 (en) 2007-12-26
FR2893841A1 (en) 2007-06-01
WO2007060182A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
CY2017038I1 (en) NEW PHARMACEUTICAL SYSTEMS CONTAINS 4- (4- (3- (4-CHLORO-3-TRIFTORMENTHYL-PHENIL) -RIDO) -3-FTHORO-PHENOXY-PYRIDIN-2-CARBOXYLIC
FR14C0069I2 (en) PHARMACEUTICAL COMPOSITION COMPRISING LURASIDONE
IL225167A (en) (p-methoxy)phenyl-sulfonamide, n-(i-butyl), n-[(2r)-hydroxy-(3r)-benzyl-propyl] derivatives
DK1799633T3 (en) Crystal forms of (-) - (1R, 2R) -3- (3-dimethylamino-1-ethyl-2-methylpropyl) phenol hydrochloride for use as active ingredient in pharmaceutical compositions
FR2892937B1 (en) MICROPARTICULAR ORAL PHARMACEUTICAL FORM ANTI-MEASURING
FR2881652B1 (en) MICROPARTICULAR ORAL PHARMACEUTICAL FORM ANTI-MEASURING
DK1725218T3 (en) Pharmaceutical composition comprising pimobendan
BRPI0511900A (en) pharmaceutical compositions
PL1771069T3 (en) N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials
DK1536792T3 (en) Pramipexole dosage form for once-daily use
DK1660104T3 (en) Pharmaceutical formulation containing lanthanum compounds
DK1651621T3 (en) 2- (Quinoxaline-5-ylsulfonylamino) benzamide compounds as CCK2 modulators
NO20053119D0 (en) Pharmaceutical intestinal composition with fentanyl for intranasal administration.
MA27380A1 (en) Heterobiaryl derivatives used as matrix metalloproteinase inhibitors
IL185035A0 (en) Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine
IL186308A (en) Pharmaceutical formulation comprising metformin hydrochloride and pioglitazone hydrochloride
JP2008510815A5 (en) Oxazolo-naphthyl acid as a plasminogen activator inhibitor type 1 (PAI-1) modulator
IS7766A (en) N- (3-methoxy-5-methylpyrazin-2-yl) -2- (4- [1,3,4-oxadiazol-2-yl] phenyl) pyridine-3-sulfonamide as an anticancer drug
BRPI0815124A2 (en) USE OF A N- (2-THIAZOLYL) AMIDE DERIVATIVE COMPOUND, COMPOUND, PHARMACEUTICAL AND COSMETIC COMPOSITION CONTAINING THE SAME
DK2918286T3 (en) A PHARMACEUTICAL FORMULATION
NO20052414L (en) Novel pyrrolidine and thiazolidine compounds, processes for their preparation and pharmaceutical compositions containing them
DE602006016010D1 (en) NEW ARYLAMIDE DERIVATIVE, SALT AND ANTIMYCOTIC AGENT CONTAINING THEREOF
SM200500011B (en) An antimycobacterial pharmaceutical composition
FR2893841B1 (en) DEPIGMENTING PHARMACEUTICAL COMPOSITION COMPRISING N- (2 - ((3- (4-BROMOPHENYL) -2-PROPENYL) AMINO) ETHYL) -5-ISOQUINOLINESULFONAMIDE (H89)
NO20054495D0 (en) Novel aniline derivatives, their preparation and use as pharmaceutical compounds

Legal Events

Date Code Title Description
TP Transmission of property
RN Application for restoration

Effective date: 20130903

FC Decision of inpi director general to approve request for restoration

Effective date: 20140211

ST Notification of lapse

Effective date: 20140402

FC Decision of inpi director general to approve request for restoration

Effective date: 20140415

TQ Partial transmission of property

Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC, FR

Effective date: 20140530

Owner name: LES LABORATOIRES D'ANJOU, FR

Effective date: 20140530

PLFP Fee payment

Year of fee payment: 11

CA Change of address

Effective date: 20160831

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19